9. INCOME TAXES AND TAX STATUS
Our net losses before income taxes for the years ended December 31, 2017 and 2016 are from domestic operations as well as losses from our wholly-owned German subsidiary. We elected to treat our German subsidiary as a disregarded entity for purposes of income taxes and accordingly, the losses from our German subsidiary has been included in our operating results.
We recorded $0.7 million in current foreign income tax expense for the year ended December 31, 2016 as a result of foreign tax withholding on licensing revenues from a Korean entity. No current or deferred tax provision or benefit was recorded for 2017 and 2016 as a result of current losses and fully deferred tax valuation allowances for all periods. We have recorded a valuation allowance to state our deferred tax assets at their estimated net realizable value due to the uncertainty related to realization of these assets through future taxable income.
On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Act. The Tax Act makes broad and complex changes to the U.S. tax code that includes a reduction to the U.S. federal corporate statutory tax rate to 21% effective in 2018. As of December 31, 2017, our accounting for the income tax effects of the Tax Act has been completed. The federal corporate tax rate reduction creates a reduction to our deferred tax assets and liabilities with a corresponding reduction to our valuation allowance.
A reconciliation between the provision for income taxes and the expected tax benefit using the federal statutory rate of 34% for the years ended December 31, 2017 and 2016 are as follows (in thousands):
|
|
|||||
|
|
2017 |
2016 |
|||
|
Tax benefit at statutory rate |
$ |
(6,548) |
$ |
(7,313) | |
|
State tax benefit |
(674) | (753) | |||
|
Impact of the Tax Act |
41,646 |
- |
|||
|
(Decrease) increase in valuation allowance |
(34,346) | 8,145 | |||
|
Research and development credit |
(129) | (97) | |||
|
Other |
51 | 18 | |||
|
|
$ |
- |
$ |
- |
|
|
|
|||||
Our deferred tax assets and liabilities relate to the following sources and differences between financial accounting and the tax bases of our assets and liabilities at December 31, 2017 and 2016 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
2016 |
||
|
Gross deferred tax assets: |
|
|
|
|
|
|
Net operating loss carry-forward |
$ |
82,168 |
|
$ |
115,296 |
|
Research and development credit |
|
8,051 |
|
|
7,922 |
|
Stock compensation |
|
1,248 |
|
|
1,885 |
|
Patents and other |
|
1,427 |
|
|
2,119 |
|
Contingent payment obligation |
|
1,409 |
|
|
1,823 |
|
Fixed assets |
|
25 |
|
|
78 |
|
Accrued liabilities |
|
49 |
|
|
54 |
|
Deferred rent |
|
20 |
|
|
19 |
|
Charitable contributions |
|
7 |
|
|
11 |
|
Deferred revenue |
|
5 |
|
|
7 |
|
Capital loss carry-forward |
|
3 |
|
|
8 |
|
Warranty reserve |
|
2 |
|
|
- |
|
Bad debt expense |
|
1 |
|
|
2 |
|
Inventory |
|
- |
|
|
1 |
|
|
|
94,415 |
|
|
129,225 |
|
Less valuation allowance |
|
(94,415) |
|
|
(129,225) |
|
Net deferred tax asset |
$ |
- |
|
$ |
- |
|
|
|
|
|
|
|
At December 31, 2017, we had cumulative NOL, research and development (“R&D”) tax credit carry-forwards and capital loss carry-forwards for income tax purposes of $328.4 million, $8.1 million and $0.01 million, respectively, which expire in varying amounts from 2018 through 2036.
Our ability to benefit from the our tax credit carry-forwards could be limited under certain provisions of the Internal Revenue Code if our ownership changes by more than 50%, as defined by Section 382 of the Internal Revenue Code of 1986 (“Section 382”). Under Section 382, an ownership change may limit the amount of NOL, capital loss and R&D credit carry-forwards that can be used annually to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50 percentage points over a three-year period. We conduct a study annually of our ownership changes. Based on the results of our studies, we have determined that we do not have any ownership changes on or prior to December 31, 2017 which would result in limitations of our NOL, capital loss or R&D credit carry-forwards under Section 382.
Uncertain Tax Positions
We file income tax returns in the U.S. federal jurisdiction and various state jurisdictions. We have identified our Federal and Florida tax returns as our only major jurisdictions, as defined. The periods subject to examination for those returns are the 1998 through 2017 tax years. The following table provides a reconciliation of our unrecognized tax benefits due to uncertain tax positions for the years ended December 31, 2017 and 2016, respectively (in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
2016 |
||
|
Unrecognized tax benefits – beginning of year |
$ |
1,370 |
|
$ |
1,370 |
|
Gross increases – tax positions in prior period |
|
- |
|
|
- |
|
Impact of the Tax Act |
|
(443) |
|
|
- |
|
Unrecognized tax benefits – end of year |
$ |
927 |
|
$ |
1,370 |
|
|
|
|
|
|
|
Future changes in the unrecognized tax benefit will have no impact on the effective tax rate so long as we maintain a full valuation allowance.
Our policy is that we recognize interest and penalties accrued on any unrecognized tax benefits as a component of our income tax expense. We do not have any accrued interest or penalties associated with any unrecognized tax benefits. For the years ended December 31, 2017 and 2016, we did not incur any income tax-related interest income, expense or penalties.